- Hypofractionated High-Dose Intensity-Modulated Radiotherapy (60 Gy at 2.5 Gy per Fraction) for Recurrent Renal Cell Carcinoma: A Case Report
-
Cho J, Kim GE, Rha KH, Ahn JB, Lee CG, Suh CO, Seong J, Keum KC, Kim SI, Lee YH
- KMID: 1785842
- J Korean Med Sci.
- 2008 Aug;23(4):740-743.
- doi: 10.3346/jkms.2008.23.4.740
A patient with renal cell carcinoma (RCC) developed synchronous bone metastasis with metachronous relapses to the bone and renal fossa. The primary lesion was initially removed surgically, and the metastatic... -
- CITED
-
- Close
- SHARE
-
- Close
- Phenylpropanoids in radioregulation: double edged sword
-
Kim W, Seong KM, Youn B
- KMID: 1107373
- Exp Mol Med.
- 2011 Jun;43(6):323-333.
- doi: 10.3858/emm.2011.43.6.034
Radiotherapy, frequently used for treatment of solid tumors, carries two main obstacles including acquired radioresistance in cancer cells during radiotherapy and normal tissue injury. Phenylpropanoids, which are naturally occurring phytochemicals... -
- CITED
-
- Close
- SHARE
-
- Close
- Preliminary experiences with intraoperative radiation therapy (IORT) for the treatment of brain tumors
-
Chung YG, Kim CY, Lee HK, Lee KC, Chu JW, Choi MS
- KMID: 927178
- J Korean Med Sci.
- 1995 Dec;10(6):449-452.
- doi: 10.3346/jkms.1995.10.6.449
Ten brain tumor patients underwent wide resection of the tumor followed by Intraoperative Radiation Therapy (IORT) at the first surgery or at the second salvage surgery after failure of conventional... -
- CITED
-
- Close
- SHARE
-
- Close
- Toxicity of Tomotherapy-Based Simultaneous Integrated Boost in Whole-Pelvis Radiation for Prostate Cancer
-
You SH, Lee JY, Lee CG
- KMID: 2070032
- Yonsei Med J.
- 2015 Mar;56(2):510-518.
- doi: 10.3349/ymj.2015.56.2.510
PURPOSE: The validity of tomotherapy-based simultaneous integrated boost (TOMOSIB) was assessed in terms of acute intestinal/urinary toxicity by comparing with 3-dimensional conformal radiotherapy (3DCRT) in cases of whole-pelvis radiation therapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Outcomes of Gleason Score < or =8 among High Risk Prostate Cancer Treated with 125I Low Dose Rate Brachytherapy Based Multimodal Therapy
-
Park DS, Gong IH, Choi DK, Hwang JH, Shin HS, Oh JJ
- KMID: 1793169
- Yonsei Med J.
- 2013 Sep;54(5):1207-1213.
- doi: 10.3349/ymj.2013.54.5.1207
PURPOSE: To investigate the role of low dose rate (LDR) brachytherapy-based multimodal therapy in high-risk prostate cancer (PCa) and analyze its optimal indications. MATERIALS AND METHODS: We reviewed the records of... -
- CITED
-
- Close
- SHARE
-
- Close
